Document Type
The Ocular Side-Effects of Vigabatrin (Sabril) Information and Guidance for Screening
Visual field screening for patients o will enable a more informed decision on whether to initiate or continue treatment with
vigabatrin.
TREATMENT OF AGE-RELATED MACULAR DEGENERATION BY INTRAVITREAL INJECTION WITH RANIZUMAB (LUCENTIS):Treatment leaflet and Patient Consent form
This leaflet provides information about the eye condition wet age-related macular degeneration (AMD).
Fluocinolone acetonide intravitreal implant for treating chronic DMO after inadequate response to prior therapy
College statement on NICE guidance TA 301 – Fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema after inadequate response to prior therapy (rapid review of technology appraisal guidance 271) December 2013
Use of Avastin (bevacizumab) in age related macular degeneration
College statement on the use of Avastin (bevacizumab) in age related macular degeneration December 2014
Statement in response to NICE announcing their positive final guidance for Eylea® for the treatment of macular oedema secondary to CRVO
Statement from The Royal College of Ophthalmologists in response to NICE announcing their positive final guidance for Eylea® for the treatment of macular oedema secondary to CRVO February 2014